Sept. 24, 2020 10:50 UTC
EMERYVILLE, Calif.–(BUSINESS WIRE)– NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) declares expanded Avenova® shopper advertising packages designed to generate larger consciousness of its antimicrobial lid and lash spray and promote online sales. NovaBay has engaged PartnerCentric, Inc. for affiliate internet marketing packages and HVM Communications for enhanced public relations that includes consumer-oriented, life-style messaging.
This press launch options multimedia. View the complete launch right here: https://www.businesswire.com/news/home/20200924005274/en/
“Since partaking PartnerCentric solely days in the past we’re already having success in gaining consciousness of Avenova via web sites that includes banner promoting and postings, with a powerful uptick in our web site visitors. Our public relations actions with HVM Communications resulted in yesterday’s nationwide community tv phase on NBC’s Right this moment present,” stated Justin Corridor, NovaBay’s CEO. “The objective of those cost-efficient packages is to extend shopper purchases of Avenova via the net channel, which is the place we see the best progress alternative to construct on our No.1 antimicrobial lid and lash spray. These packages capitalize on shopper outreach with Avenova’s refreshed branding, vibrant new packaging and life-style messaging, in addition to latest impartial laboratory outcomes displaying Avenova successfully kills the coronavirus on arduous surfaces.”
Yesterday’s Today show phase with life-style professional Jenn Falik included Avenova amongst “eight higher fundamentals that that you must learn about for fall.” Ms. Falik referred to as Avenova a sanitizing spray that can be utilized in your complete face, despite the fact that it was initially designed for eyecare. She added that Avenova may be sprayed in your face all through the day to kill any germs that end result from the frequent, however typically inadvertent, touching of the eyes, nostril and mouth.
NovaBay’s affiliate internet marketing program with PartnerCentric connects with associates similar to consumer-oriented web sites or bloggers to advertise Avenova with audience-specific on-line content material. The associates earn commissions of three% to eight% from ensuing Avenova gross sales tracked via Avenova.com. Lots of the associates additionally provide coupons or rebates the place clients obtain a reduction or money again on their purchases. To take part in Avenova’s associates program, please e mail email@example.com.
“We’re excited in regards to the early success of the Avenova program in producing larger consciousness of this modern antimicrobial spray,” stated Stephanie Harris, PartnerCentric’s Proprietor and CEO. “We sit up for constructing a significant partnership with NovaBay and bringing the mixed energy of our in-house know-how options and tenured administration workforce at PartnerCentric to this relationship.”
PartnerCentric, Inc. is the biggest woman-owned (WBE-certified) efficiency advertising company within the trade. At our core, we construct significant relationships past borders and purpose to be one of the best companions for our shoppers and for one another. Our workforce, comprised of confirmed trade veterans and strategists, connects our shoppers with the correct companions for long-term success. We make the most of a mix of proprietary in-house know-how and modern, strategic administration to drive the best ROI for among the world’s most revered manufacturers from rising startups to F500 enterprises. Our premium administration ensures that we’re 100% funded by joyful clients and our shoppers are supported by probably the most tenured account managers within the trade, with a mean of over 13 years of expertise. Uncover our new Management Suite (www.partnercentric.com/control-suite) and go to http://www.partnercentric.com to study extra about our workforce and providers.
About NovaBay Prescription drugs, Inc.: Going Past Antibiotics®
NovaBay Prescription drugs, Inc. is a biopharmaceutical firm specializing in commercializing and growing its non-antibiotic anti-infective merchandise to deal with the unmet therapeutic wants of the worldwide, topical anti-infective market with its two distinct product classes: the NEUTROX® household of merchandise and the AGANOCIDE® compounds. The Neutrox household of merchandise consists of AVENOVA® for the attention care market, CELLERX® for the aesthetic dermatology market and NEUTROPHASE® for the wound care market. The Aganocide compounds, nonetheless beneath growth, have goal purposes within the dermatology and urology markets.
Apart from historic info herein, issues set forth on this press launch are forward-looking inside the that means of the “secure harbor” provisions of the Non-public Securities Litigation Reform Act of 1995, together with statements in regards to the industrial progress and future monetary efficiency of NovaBay Prescription drugs, Inc. This launch comprises forward-looking statements which might be based mostly upon administration’s present expectations, assumptions, estimates, projections and beliefs. These statements embody, however aren’t restricted to, statements relating to all of our present advertising efforts, any potential monetary affect of our public relations campaigns and associates program, in addition to usually the Firm’s anticipated future monetary outcomes. These forward-looking statements are recognized by means of phrases similar to “uptick,” “objective,” improve,” and “progress” amongst others. These statements contain recognized and unknown dangers, uncertainties and different elements that will trigger precise outcomes or achievements to be materially totally different and adversarial from these expressed in or implied by the forward-looking statements. Elements which may trigger or contribute to such variations embody, however aren’t restricted to, dangers and uncertainties referring to the dimensions of the potential marketplace for our merchandise, the likelihood that the accessible marketplace for the Firm’s merchandise won’t be as giant as anticipated, the Firm’s merchandise won’t be able to penetrate a number of focused markets, revenues won’t be adequate to fulfill the Firm’s money wants, and any potential regulatory issues. Different dangers referring to NovaBay’s enterprise, together with dangers that might trigger outcomes to vary materially from these projected within the forward-looking statements on this press launch, are detailed in NovaBay’s newest Kind 10-Q/Okay filings with the Securities and Trade Fee, particularly beneath the heading “Danger Elements.” The forward-looking statements on this launch communicate solely as of this date, and NovaBay disclaims any intent or obligation to revise or replace publicly any forward-looking assertion besides as required by legislation.
View supply model on businesswire.com: https://www.businesswire.com/news/home/20200924005274/en/